Calder & Vance International Sanctions & Compliance Counsel

Cross-Border Transactions & Diligence · BIS / EAR

Divesting a sanctioned interest under BIS / EAR: specialist advice

A portfolio review flags a holding in a foreign technology company. The co-investor turns out to be on the Entity List (the Bureau of Industry and Security's list of parties subject to enhanced export-control restrictions under the Export Administration Regulations). The transaction documents are silent on this scenario. What must the seller do, and how quickly does the clock start?

Divesting a sanctioned interest under the BIS / EAR (the Export Administration Regulations administered by the Bureau of Industry and Security) is a distinct exercise from an OFAC-driven divestiture. The EAR does not freeze assets in the way financial-sanctions programmes do, but a continuing ownership relationship with a listed or controlled party can generate ongoing licence requirements, deemed-export exposure, and reputational consequences that accumulate with time. The exit must be structured to sever the prohibited nexus cleanly and documented to demonstrate that the divestiture was genuine.

This page covers how the BIS / EAR regime treats such holdings, where it diverges from OFAC and OFSI, what the cross-border complications are, and how Calder & Vance structures the divestiture process for cross-border businesses.

What triggers a BIS / EAR divestiture obligation in a cross-border holding?

An ownership stake can create an ongoing EAR obligation when the portfolio company is a party subject to a BIS denial order, Entity List restriction, or Unverified List concern – or when the transfer of technology, software, or technical data to that party requires a licence that is now unavailable or denied. The BIS regime targets the flow of controlled items and information, not merely financial relationships. A continuing ownership stake may involve deemed exports of controlled technology to the co-investor simply through board-level engagement, technical briefings, or access to IP.

The trigger is therefore wider than it appears. It is not just a question of whether the company itself is listed. It also turns on what controlled technology the portfolio company handles, who else owns or controls it, and what information flows occur in the ordinary course of board participation. In our cross-border practice, we regularly advise shareholders who discover mid-hold that a co-investor's listing has converted a routine investment into an ongoing EAR compliance problem. The link between the ownership stake and the technology access is the analysis that must happen first.

The cross-border dimension sharpens the problem. BIS has extraterritorial reach (jurisdiction over items and technology of US origin or produced with US-origin inputs above a de minimis threshold) that can catch a non-US investor in a non-US company if the underlying technology has a US-origin component. The divestiture analysis must therefore map both the owner's jurisdiction and the technology's origin.

How does the BIS / EAR divestiture test compare with OFAC and OFSI?

The three regimes approach the divestiture question from fundamentally different starting points, and conflating them is one of the most common errors we see in cross-border transactions.

Under OFAC, the 50 percent rule (OFAC's rule treating any entity owned 50 percent or more in the aggregate by blocked persons as itself blocked) means that a seller holding a stake in a company above that threshold is effectively holding blocked property, and the divestiture requires a specific licence or the use of an applicable general licence. The asset is frozen until authorisation is obtained. The financial-sanctions prohibition is the primary driver.

Under OFSI and the equivalent EU Council regulation position, an ownership and control test (the assessment of whether a non-listed entity is caught through a listed person's direct or indirect stake) applies. Control can exist even below a 50 percent holding, and the blocking consequence flows from that broader test.

Under the EAR, there is no equivalent asset-freeze. Instead, BIS controls the transfer, re-export, and provision of controlled items and technology. The divestiture question becomes: does the current ownership relationship involve, or will it involve, the transfer of a US-origin item or controlled technology without the required licence? If yes, the seller must act – either by obtaining a BIS licence for any continuing provision, or by exiting the relationship cleanly before further exposure occurs.

For a seller managing simultaneous OFAC and BIS concerns – which is common when a co-investor appears on both the SDN List and the Entity List – the two processes must run in parallel but are governed by separate legal standards. The OFAC-driven divestiture typically requires a specific licence where assets are frozen. The BIS-driven divestiture requires a clean severance of technology access and, where any transfer occurred prior to exit, a careful assessment of whether a voluntary self-disclosure (a VSD – the process of proactively reporting an apparent violation to the relevant regulator) is warranted.

The position above covers the standard framework. Your facts – the technology, the counterparty, the ownership structure, and the relevant regime – will determine which set of rules governs. If you are mapping a cross-regime divestiture, our team can assist.

For OFAC-driven divestitures involving blocked property, see our OFAC Divestiture service.

What is the step-by-step procedure for exiting a BIS-affected holding?

A BIS-affected divestiture does not follow a single prescribed sequence, but in our experience the following decision path reduces regulatory risk and preserves commercial optionality.

  1. Classification and nexus mapping. Identify the controlled items, software, or technology involved in the portfolio company's operations. Confirm whether any item carries a US-origin nexus sufficient to engage BIS jurisdiction. Classify any dual-use items by their ECCN (Export Control Classification Number under the US Commerce Control List) or confirm EAR99 status.
  2. Status check on all relevant parties. Screen the co-investor, the portfolio company, and any intermediate holding entities against the Entity List, Denied Persons List, and Unverified List. Check OFAC's SDN List in parallel. A party can appear on one list without appearing on another, and each carries different legal consequences.
  3. Technology-access audit. Determine whether any controlled technology has already been transferred, disclosed, or made accessible to the listed party in circumstances that required a BIS licence. If so, a prior violation may have occurred and VSD analysis is required before the divestiture closes.
  4. Licence requirement assessment. Determine whether the divestiture itself – specifically, the transfer of any controlled items or technology as part of the sale – requires a BIS licence. Certain transfers to foreign persons, including the transfer of equity in a company holding controlled technology, can constitute a deemed export requiring prior authorisation.
  5. Structuring the exit. Design the sale so that it severs the technology-access relationship as well as the financial interest. This means reviewing shareholder agreements, board access rights, IP licences, and technical-assistance arrangements. The exit must be documented to show that no further EAR-controlled activity flows to the restricted party after completion.
  6. VSD determination. If the nexus audit surfaces a prior apparent violation, assess whether a VSD is appropriate. BIS applies its own enforcement guidelines, and voluntary disclosure can be a significant mitigating factor. The decision to disclose, and the form of that disclosure, requires specialist input.
  7. Closing documentation and post-close monitoring. Ensure that the sale agreement includes representations and warranties adequate to document the exit's compliance posture, and that any ongoing relationship (for example, a transitional services arrangement) does not re-create the prohibited nexus.

The timeline for a BIS divestiture is driven by the complexity of the technology-access audit and, where a BIS licence is required, by the agency's review period for export-licence applications. That review period is not fixed and varies by the nature of the item and the parties involved – verify the current position before relying on any projection.

What are the cross-border risk flags a seller must assess?

Several risk areas consistently arise in cross-border BIS divestitures, and each of them can reopen a transaction that the seller believed was closed.

Deemed exports to the co-investor. The EAR's deemed-export rule treats the disclosure of controlled technology to a foreign national – including at a board meeting or in an investor-relations briefing – as an export to that person's country. If a listed co-investor has received such disclosure, the violation may pre-date the divestiture decision by months or years. This is often the most consequential finding of the technology-access audit.

The de minimis rule and foreign-produced items. Non-US companies sometimes underestimate BIS jurisdiction. Where a foreign product incorporates US-controlled content above the applicable de minimis threshold, BIS jurisdiction follows the item regardless of where the product was made or who now owns it. A portfolio company that produces such items is subject to the EAR even if neither the seller nor the buyer is a US person.

Re-export exposure at closing. The transfer of the portfolio company itself, if it holds inventory of US-origin items or controlled technology, can constitute a re-export requiring prior BIS authorisation. This is a step many sellers overlook until late in the process.

Parallel OFAC exposure. Where the co-investor is listed on both the Entity List and the SDN List, the financial-sanctions prohibition sits alongside the export-control problem. The OFAC-driven freeze of assets means the seller cannot complete the divestiture without either an OFAC specific licence or a confirmed applicable general licence. Running only the BIS analysis and missing the OFAC dimension is a critical error.

For cases where both OFAC and BIS concerns arise in a single divestiture, see our combined OFAC and BIS divestiture advisory service.

Secondary-sanctions risk for non-US sellers. Non-US businesses can face BIS enforcement and, separately, the risk of being named on OFAC's secondary-sanctions radar if their continued engagement with a restricted party is seen as materially supporting a sanctioned programme. The precise scope of that exposure depends on the relevant country regime and the nature of the business conducted.

When is a BIS export-licence application required before the exit can close?

A BIS licence application becomes necessary where the divestiture itself involves the transfer of an EAR-controlled item, technology, or software to a party that requires authorisation for that receipt. This most often arises in three situations.

First, where the portfolio company's assets include physical goods that are EAR-controlled and the transfer to the buyer requires BIS approval because of the buyer's jurisdiction or end-use. Second, where the transaction involves the transfer or assignment of a technology licence or technical-assistance agreement that itself constitutes a controlled transfer. Third, where the portfolio company is a foreign entity whose acquisition by the buyer is structured as a transfer of controlled US-origin technology.

In each of these situations, the seller should approach BIS well in advance of the anticipated closing date. Licence applications involve a multi-agency review process that can extend the timeline significantly. Where the item or the parties involved raise national-security or foreign-policy considerations, the review may be referred to additional government departments. Attempting to close a transaction that requires a BIS licence without obtaining it in advance is itself an EAR violation and compounds the existing risk.

If a transaction has already been flagged by BIS, or a filing has been refused, an early review of the options can preserve routes that close with delay. Contact Calder & Vance at info@caldervance.com to discuss the position.

A common misconception: "The EAR only applies to physical goods"

We regularly encounter businesses that believe BIS controls apply only to the physical movement of equipment across borders. This is incorrect, and the misconception has caused preventable enforcement exposure.

The EAR controls not only the export of physical items but also the re-export of items, the export or re-export of software, the release of technology (including through visual inspection, oral disclosure, or electronic transmission), and – critically – deemed exports of controlled technology to foreign nationals within the United States or, in the EU and UK equivalent regimes, within the exporting country.

In the divestiture context, this means that a seller reviewing a portfolio holding in a foreign technology company must consider not just whether physical goods were transferred but whether any technical data, source code, or engineering know-how was shared with the co-investor or with the portfolio company's employees who are nationals of a country subject to a licence requirement. The technology-access audit is therefore not a formality. It is the core of the BIS divestiture analysis.

We have acted for manufacturing businesses that discovered, only when preparing a divestiture, that years of routine technical collaboration with a co-investor had involved repeated deemed exports that had gone unrecognised and unreported. Addressing that history – and advising on the VSD decision – before the exit closes is the only way to avoid the problem resurfacing in a post-completion investigation.

How Calder & Vance structures a BIS divestiture engagement

Our approach to a BIS divestiture engagement is structured around the decisions that carry the greatest legal and commercial consequence for the seller.

We begin with a rapid scoping review: classifying the controlled items involved, confirming the status of all relevant parties across BIS and OFAC lists, and mapping the technology-access history. That scoping review is the foundation for every subsequent decision.

Where the audit reveals a prior apparent violation, we advise on the VSD question, scope the disclosure, and prepare the voluntary submission to BIS. Where a BIS licence is required before the exit can close, we assess eligibility, prepare and submit the application, and manage the regulator's queries through the review process. Where the exit can proceed without a licence, we design the transaction structure to sever the prohibited nexus, document the exit, and advise on the representations and warranties that should accompany the sale.

In a recent matter, a European manufacturing group discovered that its minority co-investor in an Asian joint venture had been added to the Entity List during the hold period. We assessed the deemed-export exposure, advised on the VSD decision, and structured the divestiture to close within the commercial timetable while managing the BIS disclosure in parallel. The matter was resolved without the need for a contested BIS licence proceeding.

We also address the OFAC dimension in every BIS divestiture engagement, because the two regimes frequently overlap. Where both apply, we co-ordinate the licence applications and disclosures so that the timelines and the positions taken with each agency are consistent.

Related practices

Frequently asked questions

How long does divest sanctioned interest take under BIS / EAR?
The timeline depends on whether a BIS licence application is required. Where the exit can be structured without a licence – because no controlled item or technology is being transferred to a restricted party – the divestiture can close on a commercial timetable, though the technology-access audit and VSD assessment must be completed first. Where a licence is required, the BIS multi-agency review process adds time that is not fixed and varies by item and parties. Sellers should build a material buffer into their transaction timetable and engage export-control counsel early.
What are the main risks in divesting a sanctioned interest under BIS / EAR?
The primary risks are: unrecognised prior deemed exports to the listed co-investor that constitute historic EAR violations; attempting to close without the required BIS licence; overlooking a parallel OFAC freeze that also needs resolution; and structuring the exit in a way that re-creates the prohibited technology-access relationship through a post-completion services arrangement. Each of these risks is manageable with early specialist input, but each can become an enforcement matter if it is discovered after closing.
Do we need specialist counsel for divesting a sanctioned interest?
For straightforward cases where the portfolio company does not handle EAR-controlled items, generalist advice may suffice. Where US-origin technology, a listed co-investor, or a multi-regime exposure is involved, specialist export-control and sanctions counsel is essential. The classification exercise, the VSD analysis, and the licence application process each require EAR expertise. A mis-step at any of these stages – particularly a closing that proceeds without a required BIS licence – can itself constitute an EAR violation with civil and, in the most serious cases, criminal consequences.

Talk to Calder & Vance

For a scoped view of your exposure, contact info@caldervance.com.

Discuss your matter

Written by , Export controls, dual-use, maritime and trade sanctions. View profile and publications →

Discuss this with Calder & Vance

A few lines on your situation and any deadline. We respond within two hours in business hours.

This publication is general information and does not constitute legal advice. For advice on your situation, contact info@caldervance.com.